The University of California, Irvine. Photo by mikejuinwind123 [GFDL (http://www.gnu.org/copyleft/fdl.html) or CC-BY-SA-2.5-2.0-1.0 (http://creativecommons.org/licenses/by-sa/2.5-2.0-1.0)], via Wikimedia Commons
The University of California, Irvine. Photo by mikejuinwind123 [GFDL (http://www.gnu.org/copyleft/fdl.html) or CC-BY-SA-2.5-2.0-1.0 (http://creativecommons.org/licenses/by-sa/2.5-2.0-1.0)], via Wikimedia Commons
University of California officials announced the winners of $1 million grants, including one led by UC Irvine, for  projects on Alzheimer’s disease research.

The UC Cures for Alzheimer’s Disease Initiative awards focuses on funding “cutting-edge projects primed for clinical trial,” officials said Monday.

One project will be led by UC Irvine and the other by UC San Francisco. The grant is for $1 million annually for two years.

“As a premier public research university with dedicated faculty and a wealth of resources, we are uniquely positioned to take on the seemingly insurmountable challenge of Alzheimer’s disease,” UC President Janet Napolitano said.

“These impressive projects focus our efforts on finding effective treatments for one of the most terrible, pervasive diseases of our time,” she added.

Joshua Grill, a UCI associate professor, will lead a team studying the effects of large doses of vitamin nicotinamide in helping those afflicted with Alzheimer’s.

—City News Service

 

 

Leave a comment

Your email address will not be published. Required fields are marked *